Lectin pathway inhibition as frontline therapy in TA-TMA: the good choice
Friday, October 2, 2026
10:00–11:30
Moderator:
Rafael F. Duarte, MD, PhD, FRCP (Lon)
Head of Department of Hematology and Transplantation Programme
Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain
Profesor Titular de Hematología – Universidad Autónoma de Madrid
Panelists:
Prof. Olaf Penack, MD
Director, Advanced Cellular Therapy Program
Hematology and Oncology
Charité – Universitätsmedizin Berlin
Campus Virchow Clinic
Berlin, Germany
Miguel-Angel Perales, MD, FASTCT
Chief, Adult Bone Marrow Transplantation Service
Attending Physician and Member
Division of Hematologic Malignancies, Department of Medicine
Memorial Sloan Kettering Cancer Center
Professor of Medicine
Weill Cornell Medical College
New York, USA
